VAD as bridge to recovery in anthracycline-induced cardiomyopathy and HHV6 myocarditis

Pediatrics

Volumn 134, Issue 3, 2014, Pages e894-e899

  Cavigelli Brunner, Anna ^a   Schweiger, Martin ^a   Knirsch, Walter ^a   Stiasny, Brian ^a   Klingel, Karin ^b   Kretschmar, Oliver ^a   Hübler, Michael ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Assist device; Cardiomyopathy; Congestive heart failure

Indexed keywords

ACETYLSALICYLIC ACID; ANTHRACYCLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CISPLATIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; DOXORUBICIN; HEPARIN; METHOTREXATE; MILRINONE; NITRIC OXIDE; PHENPROCOUMON;

ACUTE HEART FAILURE; ANTICOAGULATION; ARTICLE; BALLOON CATHETER; CARDIOMYOPATHY; CASE REPORT; CHILD; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART CONTRACTION; HEART DILATATION; HEART EJECTION FRACTION; HEART FUNCTION; HEART HEMODYNAMICS; HEART INDEX; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE BIOPSY; HEART RATE; HISTOPATHOLOGY; HOSPITAL DISCHARGE; HUMAN; HUMAN HERPESVIRUS 6; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEFT VENTRICULAR ASSIST DEVICE; LENGTH OF STAY; LUNG VASCULAR RESISTANCE; MYOCARDITIS; OSTEOSARCOMA; OUTPATIENT CARE; OXYGEN SATURATION; POSTOPERATIVE PERIOD; PULMONARY ARTERY OCCLUSION PRESSURE; ASSIST DEVICE; CONGESTIVE HEART FAILURE; CONVALESCENCE; EXANTHEMA SUBITUM; HEART ASSIST DEVICE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ASSIST DEVICE; CARDIOMYOPATHY; CONGESTIVE HEART FAILURE;

ANTHRACYCLINES; CHILD; FEMALE; HEART-ASSIST DEVICES; HERPESVIRUS 6, HUMAN; HUMANS; MYOCARDITIS; RECOVERY OF FUNCTION; ROSEOLOVIRUS INFECTIONS;

EID: 84907195367     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-2272     Document Type: Article

References (22)

1. Castells E, Roca J, Miralles A, et al. Recovery of ventricular function with a left ventricular axial pump in a patient with end-stage toxic cardiomyopathy not a candidate for heart transplantation: first experience in Spain. Transplant Proc. 2009;41 (6):2237-2239
2. Freilich M, Stub D, Esmore D, et al. Recovery from anthracycline cardiomyopathy after long-term support with a continuous flow left ventricular assist device. J Heart Lung Transplant. 2009;28(1):101-103
3. Khan N, Husain SA, Husain SI, et al. Remission of chronic anthracycline-induced heart failure with support from a continuous-flow left ventricular assist device. Tex Heart Inst J. 2012;39(4):554-556
4. Ando M, Nishimura T, Takewa Y, et al. What is the ideal off-test trial for continuous-flow ventricular-assist-device explantation? Intracircuit back-flow analysis in a mock circulation model. J Artif Organs. 2011;14 (1):70-73
5. Dandel M, Weng Y, Siniawski H, et al. Heart failure reversal by ventricular unloading in patients with chronic cardiomyopathy: criteria for weaning from ventricular assist devices. Eur Heart J. 2011;32(9):1148-1160
6. Madigan JD, Barbone A, Choudhri AF, et al. Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device. J Thorac Cardiovasc Surg. 2001;121(5):902-908
7. Wu AH. Cardiotoxic drugs: clinical monitoring and decision making. Heart. 2008;94 (11):1503-1509
8. Chatterjee K, Zhang J, Honbo N, Karliner JS. Doxorubicin cardiomyopathy. Cardiology. 2010;115(2):155-162
9. Kumar S, Marfatia R, Tannenbaum S, Yang C, Avelar E. Doxorubicin-induced cardiomyopathy 17 years after chemotherapy. Tex Heart Inst J. 2012;39(3):424-427
10. Maybaum S, Kamalakannan G, Murthy S. Cardiac recovery during mechanical assist device support. Semin Thorac Cardiovasc Surg. 2008;20(3):234-246
11. Yee-Guardino S, Gowans K, Yen-Lieberman B, et al. Beta-herpesviruses in febrile children with cancer. Emerg Infect Dis. 2008;14 (4):579-585
12. Comar M, D'Agaro P, Campello C, et al. Human herpes virus 6 in archival cardiac tissues from children with idiopathic dilated cardiomyopathy or congenital heart disease. J Clin Pathol. 2009;62(1):80-83
13. Birks EJ, George RS, Firouzi A, et al. Longterm outcomes of patients bridged to recovery versus patients bridged to transplantation. J Thorac Cardiovasc Surg. 2012; 144(1):190-196
14. Miera O, Potapov EV, Redlin M, et al. First experiences with the HeartWare ventricular assist system in children. Ann Thorac Surg. 2011;91(4):1256-1260
15. D'Alessandro D, Forest SJ, Lamour J, Hsu D, Weinstein S, Goldstein D. First reported use of the heartware HVAD in the US as bridge to transplant in an adolescent. Pediatr Transplant. 2012;16(8):E356-E359
16. Kirklin JK, Pearce FB, Pamboukian SV, et al. Implantation of the HeartWare HVAD in a child after a recent thromboembolic stroke. Ann Thorac Surg. 2012;93(3):977-978
17. Potapov EV, Weng Y, Jurmann M, Lehmkuhl H, Hetzer R. Bridging to transplantability with a ventricular assist device. J Thorac Cardiovasc Surg. 2005;130(3):930
18. Wieselthaler GM, O Driscoll G, Jansz P, Khaghani A, Strueber M; HVAD Clinical Investigators. Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial. J Heart Lung Transplant. 2010;29(11):1218-1225
19. Dandel M, Weng Y, Siniawski H, et al. Preexplant stability of unloading-promoted cardiac improvement predicts outcome after weaning from ventricular assist devices. Circulation. 2012;126(11 suppl 1): S9-S19
20. Formica P, Murthy S, Edwards P, Goldstein D, Maybaum S. A structured 3-step approach to evaluate cardiac recovery with continuous flow circulatory support. J Heart Lung Transplant. 2010;29(12):1440-1442
21. Potapov EV, Schweiger M, Krabatsch T. Percutaneous balloon occlusion of a left ventricular assist device outflow cannula to facilitate evaluation of myocardial recovery. J Heart Lung Transplant. 2011;30(11):1300-1301
22. Birks EJ, Tansley PD, Hardy J, et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med. 2006;355(18):1873-1884